Cardiovascular disease remains the principal cause of death and
disability among patients with diabetes mellitus. Diabetes exacerbates
mechanisms underlying atherosclerosis and heart failure. Unfortunately, these
mechanisms are not adequately modulated by therapeutic strategies focusing
solely on optimal glycemic control with currently available drugs or approaches.
In the setting of multi-factorial risk reduction with statins and other lipid
lowering agents, anti-hypertensive therapies, and anti-hyperglycemic treatment
strategies, cardiovascular complication rates are falling, yet remain higher for
patients with diabetes than for those without. This review considers the
mechanisms, history, controversies, new pharmacologic agents, and recent
evidence for current guidelines for cardiovascular management in the patient
with diabetes mellitus to support evidence-based care in the patient with
diabetes and heart disease outside of the acute care setting.